Markets:

Overview

News

Currencies

International

Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

5.425 +0.035 (+0.65%)

Streaming Delayed Price Updated: 11:44 AM EDT, Jul 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing

July 24, 2023

From AbCellera Biologics Inc.

Via Business Wire

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

Recap: AbCellera Biologics Q1 Earnings ↗

May 04, 2023

Via Benzinga

4 Analysts Have This to Say About AbCellera Biologics ↗

February 28, 2023

Via Benzinga

Preview: AbCellera Biologics's Earnings ↗

February 20, 2023

Via Benzinga

InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday ↗

July 12, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom ↗

July 08, 2023

AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.

Via InvestorPlace

AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023

July 06, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023

May 29, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients

May 24, 2023

From AbCellera Biologics Inc.

Via Business Wire

Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 23, 2023

Gainers

Via Benzinga

7 Growth Stocks That Could Double Your Money in 2023 ↗

May 14, 2023

For investors that really want to roll the dice, these are the enticing growth stocks that could double your money.

Via InvestorPlace

AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript ↗

May 05, 2023

ABCL earnings call for the period ending March 31, 2023.

Via The Motley Fool

AbCellera Reports Q1 2023 Business Results

May 04, 2023

From AbCellera Biologics Inc.

Via Business Wire

How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies ↗

April 28, 2023

Check out these compelling opportunities.

Via The Motley Fool

7 Stocks Under $10 That Analysts Love ↗

April 24, 2023

While these ideas might seem super cheap in a bad way, these stocks under $10 also rank among Wall Street analysts’ top picks.

Via InvestorPlace

AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023

April 17, 2023

From AbCellera Biologics Inc.

Via Business Wire

1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy ↗

April 13, 2023

These companies are leading the way in using AI in healthcare.

Via The Motley Fool

7 Best Stocks Under $10 to Buy in April ↗

April 11, 2023

Although these stocks under $10 to buy may be cheap, their underlying businesses could yield significant upside.

Via InvestorPlace

AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023

April 11, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023

April 06, 2023

From AbCellera Biologics Inc.

Via Business Wire

7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗

April 05, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Via InvestorPlace

7 Stocks to Bet On if You Want to Be Richer Than Elon Musk ↗

March 22, 2023

If you can handle the heat of extreme speculation, you may want to throw some gambling funds at these stocks that can make you rich.

Via InvestorPlace

AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease

March 22, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023

March 14, 2023

From AbCellera Biologics Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 ↗

February 28, 2023

Via Benzinga

AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023

February 23, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript ↗

February 21, 2023

ABCL earnings call for the period ending December 31, 2022.

Via The Motley Fool

AbCellera Reports Full Year 2022 Business Results

February 21, 2023

From AbCellera Biologics Inc.

Via Business Wire

The 7 Most Undervalued Biotech Stocks to Buy in February 2023 ↗

February 02, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

Via InvestorPlace

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.